The growing presence of multinational pharmaceutical companies in emerging economies is improving the availability of ulcer treatment drugs. These companies are expanding their distribution networks and investing in local markets. Such initiatives are supporting overall industry growth.
The Antiulcerant Drugs Market is projected to reach US$ 51.01 billion by 2031, growing at a CAGR of 4.4%...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek